EUVIMEDEUVIMED entdecken
Crossref

Long term efficacy of pneumatic dilation in type I and II achalasia

P Scala, R M Zagari, M Montagnani, A Ioannou, D Mandolesi, A Vestito, F Bombaci, E Mussomeli, F Torresan

Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S12-S13

DOI: 10.1055/s-0046-1820657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von P Scala und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Achalasia is a chronic degenerative disease affecting the esophageal motility. The treatment of achalasia is mainly symptomatic, aimed at symptom relief by reducing the LES pressure. The main treatments for achalasia are pneumatic dilation (PD), Heller laparoscopic myotomy (LHM), and endoscopic peroral myotomy (POEM), each with specific risks and benefits. The effectiveness of treatments tends to decline over time, and studies comparing the three therapeutic options have provided conflicting results in the long-term. Over the last two decades, the introduction of High-resolution manometry (HRM) enabled the identification of 3 types of achalasia, allowing a more precise and individualized treatment approach. The latest ESGE 2020 and the ACG 2020 guidelines recommended graded pneumatic dilation as first line treatment for type I and type II achalasia. This study aims to evaluate the efficacy and safety of graded pneumatic dilation in the treatment of type I and type II achalasia in our center, over a 10-year follow-up.

Methods

This is a single-center, retrospective, observational study designed designed and realized in our tertiary referral Gastroenterology Unit. From January 2009 to December 2019, we enrolled a total of 73 patients, 23 with type I achalasia and 50 with type II achalasia. The enrolled patients underwent a graded dilation protocol. The treatment was based on up to three incremental dilations as needed (30–35–40 mm caliber). Fifty-seven patients completed a 5-year follow-up, and 23 patients completed a 10-year follow-up. The primary outcome was clinical remission, defined as an Eckardt score≤3 during an annual clinical follow-up. The secondary outcome was the rate of postprocedural complications and subgroup analysis to evaluate the factors associated with treatment failure. A Kaplan-Meier curve was constructed for the time to treatment failure. The subgroup analysis on the time to treatment failure was performed using univariate Cox regressions.

Results

The cumulative success rate of pneumatic dilation was 94.4% at 2 years (95%CI: 85.9%-97.9%), 91.5% at 5 years (95%CI:82.0%-96.1% CI), and 81.9% at 10 years (95%CI 68.1%-90.1% CI). In the subgroup analysis, the need for multiple dilations was associated with treatment failure. Treatment failure was not associated with age, gender, type of achalasia, or clinical severity as assessed by the Eckardt score before dilation. The major complication rate was 1.3%: a single contained perforation that was managed conservatively.

Conclusions

This retrospective, observational, single-center study demonstrates that graded pneumatic dilation is a safe and effective long-term treatment for patients with type I and type II achalasia. Our findings indicate the reliability of pneumatic dilation with a graded on-demand approach as a highly effective treatment option for achalasia. These results warrant the graded PD technique as a viable first-line treatment in type I and type II achalasia patients, as an alternative to Heller myotomy or POEM. Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Scala, P., Zagari, R. M., Montagnani, M., Ioannou, A., Mandolesi, D., Vestito, A., Bombaci, F., Mussomeli, E., & Torresan, F. (2026). Long term efficacy of pneumatic dilation in type I and II achalasia. Endoscopy, 58(S 03 S 03), S12-S13. https://doi.org/10.1055/s-0046-1820657

Vancouver

Scala P, Zagari RM, Montagnani M, Ioannou A, Mandolesi D, Vestito A, et al. Long term efficacy of pneumatic dilation in type I and II achalasia. Endoscopy. 2026;58(S 03 S 03):S12-S13. doi:10.1055/s-0046-1820657

BibTeX
@article{Scala2026,
  author = {Scala, P and Zagari, R M and Montagnani, M and Ioannou, A and Mandolesi, D and Vestito, A and Bombaci, F and Mussomeli, E and Torresan, F},
  title = {Long term efficacy of pneumatic dilation in type I and II achalasia},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {S 03 S 03},
  pages = {S12--S13},
  doi = {10.1055/s-0046-1820657}
}
Kostenlos starten →